| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.39 | 0.002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |